Enhanced GPVI-dependent platelet pro-adhesive activity in patients with advanced coronary artery disease

Farshad Heydari1, Ehteramolsadat Hosseini1, Faranak Kargar2,3

  • 1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

Insights

Patients with advanced coronary artery disease (CAD) show increased platelet adhesion, linked to higher GPVI receptor expression. These findings highlight a prothrombotic state and suggest platelet indices may serve as diagnostic markers.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Platelet Physiology

Background:

  • Platelet activation is central to coronary artery disease (CAD), involving proaggregatory and proinflammatory states.
  • The proadhesive phenotype, mediated by GPVI and integrin α₂β₁, is crucial in CAD pathogenesis but underexplored in advanced stages.
  • Limited insight exists into platelet adhesion receptor expression and function in patients with advanced CAD undergoing coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To comprehensively assess adhesion receptor expression (GPVI, α₂β₁) and collagen-dependent platelet adhesion in advanced CAD patients.
  • To compare these parameters between CAD patients scheduled for CABG and healthy controls.
  • To investigate the correlation between platelet adhesion, receptor expression, and platelet indices.

Main Methods:

  • Flow cytometry was used to analyze GPVI, integrin α₂β₁, and P-selectin expression on platelets from 20 advanced CAD patients and healthy controls.
  • Collagen-dependent platelet adhesion and spreading were evaluated using immunofluorescence microscopy.
  • Correlations were established between adhesion parameters, receptor expression, and platelet indices (MPV, PDW).

Main Results:

  • Advanced CAD patients exhibited significantly higher expression of GPVI and P-selectin, but not α₂β₁, compared to controls.
  • Increased platelet adhesion and spreading on collagen matrices were observed in CAD patients.
  • Platelet functional activity strongly correlated with GPVI expression and platelet indices like MPV and PDW.

Conclusions:

  • This study reveals a heightened proadhesive platelet phenotype in advanced CAD, associated with increased GPVI expression and specific platelet indices.
  • This proadhesive state may elevate the risk of pre-CABG prothrombotic complications.
  • Platelet indices (MPV, PDW) show potential as indirect surrogate markers for platelet adhesive potential, with the adhesion profile demonstrating high diagnostic accuracy for CAD.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
430
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
202
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K